Connor, Clark & Lunn Investment Management (CC&L)’s Globus Medical GMED Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,539	Closed	-$807K	–	1298
2022 Q3	$807K	Buy	+13,539	New	+$815K	0.01%	702
2020 Q1	–	Sell	-7,200	Closed	-$424K	–	1073
2019 Q4	$424K	Buy	+7,200	New	+$391K	﹤0.01%	693
2016 Q4	–	Sell	-9,600	Closed	-$217K	–	922
2016 Q3	$217K	Buy	+9,600	New	+$226K	﹤0.01%	723
2014 Q4	–	Sell	-22,700	Closed	-$447K	–	606
2014 Q3	$447K	Sell	22,700 -900	-4%	-$18.5K	﹤0.01%	406
2014 Q2	$601K	Sell	23,600 -600	-2%	-$14.5K	﹤0.01%	370
2014 Q1	$710K	Buy	24,200 +7,700	+47%	+$183K	0.01%	434
2013 Q4	$354K	Buy	+16,500	New	+$306K	﹤0.01%	562

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s GMED Position: Q4 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Globus Medical (GMED) in Q4 2022, closing a stake of 13,539 shares — an estimated $807K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in GMED in Q4 2013 and held it in 7 quarters. The position peaked at $807K in Q3 2022. 390 funds tracked by Wall St. Rank hold GMED as of Q4 2022.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Globus Medical position as of Q4 2022 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 13,539 Globus Medical shares in Q4 2022, an estimated $807K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Globus Medical in Q4 2013 and held it in 7 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Globus Medical position peaked at $807K in Q3 2022.
390 funds tracked by Wall St. Rank held Globus Medical as of Q4 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2022, filed 10 Feb 2023.